GT
MXL icon

Glenmede Trust’s MaxLinear MXL Stock Holding History

Glenmede Trust’s Portfolio MXL Stock Details MXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Sell
12,188
-25,648
-68% -$1.81M 0.01% 649
2026
Q1 		$658K Buy
37,836
+15,072
+66% +$271K ﹤0.01% 864
2025
Q4 		$397K Buy
+22,764
New +$371K ﹤0.01% 1027
2022
Q4 		– Sell
-9,931
Closed -$323K – 1321
2022
Q3 		$323K Sell
9,931
-3,078
-24% -$114K ﹤0.01% 929
2022
Q2 		$442K Buy
13,009
+1,782
+16% +$74.7K ﹤0.01% 893
2022
Q1 		$655K Sell
11,227
-288
-3% -$17.5K ﹤0.01% 827
2021
Q4 		$868K Sell
11,515
-3,279
-22% -$210K ﹤0.01% 780
2021
Q3 		$728K Sell
14,794
-444
-3% -$21.5K ﹤0.01% 789
2021
Q2 		$647K Sell
15,238
-738
-5% -$27.5K ﹤0.01% 807
2021
Q1 		$544K Sell
15,976
-11,810
-43% -$421K ﹤0.01% 824
2020
Q4 		$1.06M Buy
27,786
+6,555
+31% +$190K 0.01% 650
2020
Q3 		$493K Buy
21,231
+5,198
+32% +$128K ﹤0.01% 786
2020
Q2 		$344K Buy
16,033
+15,538
+3,139% +$268K ﹤0.01% 866
2020
Q1 		$10K Hold
495
– – ﹤0.01% 2428
2019
Q4 		$10K Sell
495
-563
-53% -$11.7K ﹤0.01% 2428
2019
Q3 		$23K Sell
1,058
-1,048,186
-100% -$23.2M ﹤0.01% 1984
2019
Q2 		$24.6M Sell
1,049,244
-482,325
-31% -$11.7M 0.11% 263
2019
Q1 		$39.1M Sell
1,531,569
-95,240
-6% -$2.08M 0.18% 174
2018
Q4 		$28.6M Sell
1,626,809
-344,248
-17% -$6.3M 0.14% 219
2018
Q3 		$39.2M Sell
1,971,057
-57,171
-3% -$1.04M 0.16% 209
2018
Q2 		$31.6M Buy
2,028,228
+248,460
+14% +$5.02M 0.14% 230
2018
Q1 		$47M Hold
1,779,768
– – 0.2% 152
2017
Q4 		$47M Sell
1,779,768
-19,694
-1% -$492K 0.2% 152
2017
Q3 		$42.7M Buy
1,799,462
+150,441
+9% +$3.62M 0.19% 159
2017
Q2 		$46.2M Hold
1,649,021
– – 0.22% 127
2017
Q1 		$46.2M Buy
1,649,021
+456,103
+38% +$11.7M 0.22% 127
2016
Q4 		$26M Buy
1,192,918
+708,427
+146% +$14.7M 0.14% 246
2016
Q3 		$9.82M Buy
+484,491
New +$9.52M 0.06% 361

Other funds holding MXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Glenmede Trust's MXL Position: Q2 2026 in Review

Glenmede Trust reduced its MaxLinear (MXL) stake by 68% in Q2 2026, selling an estimated $1.81M and leaving 12,188 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #649.

Glenmede Trust first reported a position in MXL in Q3 2016 and has held it in 28 quarters since. The position peaked at $47M in Q1 2018. 432 funds tracked by Wall St. Rank hold MXL as of Q2 2026.

  • Glenmede Trust held 12,188 shares of MaxLinear worth $1.56M as of Q2 2026.
  • Glenmede Trust sold 25,648 MaxLinear shares in Q2 2026, an estimated $1.81M.
  • MaxLinear made up 0.01% of Glenmede Trust's portfolio in Q2 2026, its #649 holding.
  • Glenmede Trust first reported a position in MaxLinear in Q3 2016 and has held it in 28 quarters since.
  • Glenmede Trust's MaxLinear position peaked at $47M in Q1 2018.
  • 432 funds tracked by Wall St. Rank held MaxLinear as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.